Dyadic International, Inc. (NASDAQ:DYAI) Q2 2024 Earnings Call Transcript
Dyadic International, Inc. (NASDAQ:DYAI) Q2 2024 Earnings Call Transcript August 13, 2024Dyadic International, Inc. reports earnings inline with expectations.
Dyadic International Inc (DYAI)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bandera Partners Gregory Bylinsky And Jefferson Gramm | 1,566,908 | $2,319,024 | 0.84% | |
| 2. | Renaissance Technologies Jim Simons | 21,200 | $31,376 | +26% | 0% |
| 3. | 11,400 | $16,872 | +850% | 0% | |
| 4. | Citadel Investment Group Ken Griffin | 5,844 | $8,649 | -39% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.60 | 3,320 | Officer | 9,650 | 2021-06-03 | Filing | |
| $3.89 | 174 | Officer | 6,330 | 2021-06-02 | Filing | |
| $3.83 | 6,156 | Officer | 6,156 | 2021-06-02 | Filing | |
| $3.60 | 1,350 | Officer | 35,850 | 2021-06-03 | Filing | |
| $3.70 | 16,000 | Officer | 34,500 | 2021-06-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.14 | 150,000 | Large Shareholder | 3,548,528 | 2021-08-11 | Filing | |
| $4.16 | 25,000 | Large Shareholder | 3,698,528 | 2021-07-27 | Filing | |
| $3.41 | 1,089 | Officer | 0 | 2022-07-08 | Filing | |
| $3.50 | 7,854 | Officer | 0 | 2022-07-07 | Filing | |
| $4.10 | 28,767 | Large Shareholder, Officer, Director | 4,244,015 | 2021-12-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 826,301 | $1,330,344 | 0.56% | |
| 2. | 803,917 | $1,294,307 | 0% | |
| 3. | 250,000 | $402,500 | 0.02% | |
| 4. | 248,614 | $400,268 | 0% | |
| 5. | 222,696 | $358,617 | 0% |
News See All
Dyadic International, Inc. (NASDAQ:DYAI) Q1 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, good evening, and welcome to Dyadic International's Q1 2024 Conference Call. Currently, all participants are in a listen-only mode.
Dyadic International, Inc. (NASDAQ:DYAI) Q4 2023 Earnings Call Transcript
Dyadic International, Inc. misses on earnings expectations. Reported EPS is $-0.08 EPS, expectations were $-0.07.
Dyadic International, Inc. (NASDAQ:DYAI) Q3 2023 Earnings Call Transcript
Operator: Good evening, and welcome to the Dyadic International's Third Quarter 2023 Financial Results Conference Call. Currently all participants are in a listen-only mode.
Dyadic International, Inc. (NASDAQ:DYAI) Q2 2023 Earnings Call Transcript
Operator: Good evening, and welcome to Dyadic International's Second Quarter 2023 Financial Results Conference Call. Currently, all participants are in a listen-only mode.
Dyadic International, Inc. (NASDAQ:DYAI) Q1 2023 Earnings Call Transcript
Operator: Good evening, and welcome to Dyadic International's First Quarter 2023 Financial Results Conference Call. Currently, all participants are in a listen-only mode.
Dyadic International, Inc. (NASDAQ:DYAI) Q4 2022 Earnings Call Transcript
Operator: Good evening, and welcome to Dyadic International's Fiscal Year 2022 Financial Results Conference Call. Currently, all participants are in a listen-only mode.
Is DYAI Stock A Buy Here?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
10 Best Biotech Stocks Under $6 in 2021
In this article we will take a look at the 10 best biotech stocks under $6 in 2021.
5 Best Biotech Stocks Under $6 in 2021
Seelos Therapeutics, Inc. (NASDAQ: SEEL) is a New York-based biotech firm that develops and sells drugs related to treatment of the central nervous system, respiratory, and other disorders.